Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1874 1
1882 1
1939 1
1956 2
1964 1
1965 1
1967 2
1971 1
1975 1
1978 1
1979 1
1980 1
1981 5
1982 1
1983 3
1985 3
1986 2
1987 2
1989 4
1990 2
1992 5
1993 3
1994 2
1995 3
1996 5
1997 7
1998 2
1999 2
2000 6
2001 6
2002 2
2003 4
2004 3
2005 4
2006 7
2007 6
2008 4
2009 10
2010 8
2011 11
2012 9
2013 13
2014 14
2015 8
2016 9
2017 9
2018 10
2019 13
2020 8
2021 13
2022 15
2023 14
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

246 results

Results by year

Filters applied: . Clear all
Page 1
Silent progression in disease activity-free relapsing multiple sclerosis.
University of California, San Francisco MS-EPIC Team; Cree BAC, Hollenbach JA, Bove R, Kirkish G, Sacco S, Caverzasi E, Bischof A, Gundel T, Zhu AH, Papinutto N, Stern WA, Bevan C, Romeo A, Goodin DS, Gelfand JM, Graves J, Green AJ, Wilson MR, Zamvil SS, Zhao C, Gomez R, Ragan NR, Rush GQ, Barba P, Santaniello A, Baranzini SE, Oksenberg JR, Henry RG, Hauser SL. University of California, San Francisco MS-EPIC Team, et al. Among authors: bevan c. Ann Neurol. 2019 May;85(5):653-666. doi: 10.1002/ana.25463. Epub 2019 Mar 30. Ann Neurol. 2019. PMID: 30851128 Free PMC article.
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.
Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, Inman J, Arnow S, Devereux M, Abounasr A, Nobuta H, Zhu A, Friessen M, Gerona R, von Büdingen HC, Henry RG, Hauser SL, Chan JR. Green AJ, et al. Among authors: bevan c. Lancet. 2017 Dec 2;390(10111):2481-2489. doi: 10.1016/S0140-6736(17)32346-2. Epub 2017 Oct 10. Lancet. 2017. PMID: 29029896 Clinical Trial.
Differential Diagnosis of Tumor-like Brain Lesions.
Perez Giraldo GS, Singer L, Cao T, Jamshidi P, Dixit K, Kontzialis M, Castellani R, Pytel P, Anadani N, Bevan CJ, Grebenciucova E, Balabanov R, Cohen BA, Graham EL. Perez Giraldo GS, et al. Among authors: bevan cj. Neurol Clin Pract. 2023 Oct;13(5):e200182. doi: 10.1212/CPJ.0000000000200182. Epub 2023 Aug 30. Neurol Clin Pract. 2023. PMID: 37664132 Review.
Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions.
Anderson A, Rowles W, Poole S, Balan A, Bevan C, Brandstadter R, Ciplea AI, Cooper J, Fabian M, Hale TW, Jacobs D, Kakara M, Krysko KM, Longbrake EE, Marcus J, Repovic P, Riley CS, Romeo AR, Rutatangwa A, West T, Hellwig K, LaHue SC, Bove R. Anderson A, et al. Among authors: bevan c. Ann Clin Transl Neurol. 2023 Nov;10(11):2053-2064. doi: 10.1002/acn3.51893. Epub 2023 Sep 7. Ann Clin Transl Neurol. 2023. PMID: 37675826 Free PMC article.
The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer.
Constantin TA, Varela-Carver A, Greenland KK, de Almeida GS, Olden E, Penfold L, Ang S, Ormrod A, Leach DA, Lai CF, Ainscow EK, Bahl AK, Carling D, Fuchter MJ, Ali S, Bevan CL. Constantin TA, et al. Among authors: bevan cl. Br J Cancer. 2023 Jun;128(12):2326-2337. doi: 10.1038/s41416-023-02252-8. Epub 2023 Apr 19. Br J Cancer. 2023. PMID: 37076563 Free PMC article.
Evaluation of the carcinogenicity of carbon tetrachloride.
Cohen SM, Bevan C, Gollapudi B, Klaunig JE. Cohen SM, et al. Among authors: bevan c. J Toxicol Environ Health B Crit Rev. 2023 Aug 18;26(6):342-370. doi: 10.1080/10937404.2023.2220147. Epub 2023 Jun 6. J Toxicol Environ Health B Crit Rev. 2023. PMID: 37282619 Review.
Achieving safer maternity care in the UK.
Knight M, Bevan C. Knight M, et al. Among authors: bevan c. BMJ. 2021 Jan 12;372:n45. doi: 10.1136/bmj.n45. BMJ. 2021. PMID: 33436374 No abstract available.
Liver X Receptors and Male (In)fertility.
Jarvis S, Williamson C, Bevan CL. Jarvis S, et al. Among authors: bevan cl. Int J Mol Sci. 2019 Oct 29;20(21):5379. doi: 10.3390/ijms20215379. Int J Mol Sci. 2019. PMID: 31671745 Free PMC article. Review.
AMPK activation protects against prostate cancer by inducing a catabolic cellular state.
Penfold L, Woods A, Pollard AE, Arizanova J, Pascual-Navarro E, Muckett PJ, Dore MH, Montoya A, Whilding C, Fets L, Mokochinski J, Constantin TA, Varela-Carver A, Leach DA, Bevan CL, Nikitin AY, Hall Z, Carling D. Penfold L, et al. Among authors: bevan cl. Cell Rep. 2023 Apr 25;42(4):112396. doi: 10.1016/j.celrep.2023.112396. Epub 2023 Apr 15. Cell Rep. 2023. PMID: 37061917 Free PMC article.
Pelvic inflammatory disease.
Bevan C, Ridgway GL. Bevan C, et al. Br J Obstet Gynaecol. 1992 Dec;99(12):944-5. doi: 10.1111/j.1471-0528.1992.tb13693.x. Br J Obstet Gynaecol. 1992. PMID: 1477012 No abstract available.
246 results